Metis Global Partners’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.39M Buy
77,428
+7,530
+11% +$344K 0.08% 202
2025
Q4
$3.1M Buy
69,898
+4,671
+7% +$201K 0.07% 224
2025
Q3
$2.75M Buy
65,227
+17,279
+36% +$697K 0.06% 254
2025
Q2
$1.76M Buy
47,948
+12,257
+34% +$455K 0.05% 340
2025
Q1
$1.36M Buy
35,691
+6,134
+21% +$228K 0.04% 397
2024
Q4
$1.12M Buy
29,557
+3,017
+11% +$121K 0.03% 409
2024
Q3
$1.08M Buy
26,540
+6,927
+35% +$262K 0.03% 424
2024
Q2
$672K Buy
19,613
+2,719
+16% +$85.6K 0.02% 482
2024
Q1
$535K Buy
16,894
+289
+2% +$8.79K 0.02% 541
2023
Q4
$509K Buy
16,605
+2,249
+16% +$72.2K 0.02% 543
2023
Q3
$476K Buy
14,356
+1,003
+8% +$32K 0.02% 536
2023
Q2
$410K Buy
+13,353
New +$386K 0.02% 563

Other funds holding OHI

Metis Global Partners's OHI Position: Q1 2026 in Review

Metis Global Partners increased its Omega Healthcare (OHI) stake by 11% in Q1 2026, buying an estimated $344K and bringing the position to 77,428 shares worth $3.39M. The position accounts for 0.08% of the portfolio, ranked #202.

Metis Global Partners first reported a position in OHI in Q2 2023 and has held it in 12 quarters since. 741 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Metis Global Partners held 77,428 shares of Omega Healthcare worth $3.39M as of Q1 2026.
  • Metis Global Partners bought 7,530 Omega Healthcare shares in Q1 2026, an estimated $344K.
  • Omega Healthcare made up 0.08% of Metis Global Partners's portfolio in Q1 2026, its #202 holding.
  • Metis Global Partners first reported a position in Omega Healthcare in Q2 2023 and has held it in 12 quarters since.
  • 741 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.